These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 413342)

  • 1. Experiments on immunoprophylaxis against Chagas' disease.
    Hanson WL
    Adv Exp Med Biol; 1977; 93():281-3. PubMed ID: 413342
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoprophylaxis against Chagas' disease.
    Teixeira AR
    Adv Exp Med Biol; 1977; 93():243-80. PubMed ID: 413341
    [No Abstract]   [Full Text] [Related]  

  • 3. Chagas' disease: potential for immunoprophylaxis.
    Lancet; 1980 Mar; 1(8166):466. PubMed ID: 6102192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of gamma rays on blood forms of Trypanosoma cruzi. Experimental study in mice].
    Takeda GK; Campos R; Kieffer J; Moreira AA; Amato Neto V; Castilho VL; Pinto PL; Duarte MI
    Rev Inst Med Trop Sao Paulo; 1986; 28(1):15-8. PubMed ID: 3094131
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trials for the use of gamma rays in the prevention of Trypanosoma cruzi transfusion infection].
    Amato Neto V; Pasternak J; Matsubara L; Hammerschlak N; Carignani FL
    Rev Soc Bras Med Trop; 1996; 29(6):613-4. PubMed ID: 9011890
    [No Abstract]   [Full Text] [Related]  

  • 8. A vaccination procedure against Trypanosoma cruzi infection in mice by nonspecific immunization.
    Ortiz-Ortiz L; Gonzalez-Mendoza A; Lamoyi E
    J Immunol; 1975 Apr; 114(4):1424-5. PubMed ID: 804010
    [No Abstract]   [Full Text] [Related]  

  • 9. Biolistic DNA vaccination against Trypanosoma infection.
    Bryan M; Guyach S; Norris KA
    Methods Mol Biol; 2013; 940():305-15. PubMed ID: 23104351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Chagas' disease: studies on the stability of a protective antigen.
    Cappa SM; Cantarella AI; Lajmanovich S; Segura ES
    J Parasitol; 1976 Feb; 62(1):130-1. PubMed ID: 815532
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine development against Trypanosoma cruzi and Chagas disease.
    Vázquez-Chagoyán JC; Gupta S; Garg NJ
    Adv Parasitol; 2011; 75():121-46. PubMed ID: 21820554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
    Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL
    Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Trypanosoma cruzi using fecal forms of homologous parasites from juvenilized or normal vectors of Chagas' disease and by passive transfer of immune blood.
    Perlowagora-Szumlewicz A
    Rev Bras Malariol Doencas Trop; 1977; 29():5-21. PubMed ID: 120952
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection against challenge of mice experimentally infected with Trypanosoma cruzi.
    Szarfman A; Schmuñis GA; Vattuone NH; Yanovsky JF; Cossio PM; Arana RM
    Tropenmed Parasitol; 1977 Sep; 28(3):333-41. PubMed ID: 410127
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental Chagas' disease: protective activity in relation with subcellular fractions of the parasite.
    Segura EL; Paulone I; Cerisola J; Cappa SM
    J Parasitol; 1976 Feb; 62(1):131-3. PubMed ID: 815533
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi.
    Basso B; Moretti E; Fretes R
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):119-23. PubMed ID: 24275040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protection of mice with Trypanosoma lewisi antigen and its fractions against experimental Trypanosoma cruzi infection].
    Fernández de Lara WG
    Rev Inst Med Trop Sao Paulo; 1972; 14(5):301-5. PubMed ID: 4630386
    [No Abstract]   [Full Text] [Related]  

  • 19. Trypanosoma cruzi culture used as vaccine to prevent chronic Chagas' disease in mice.
    Basombrío MA; Besuschio S
    Infect Immun; 1982 Apr; 36(1):351-6. PubMed ID: 6804390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice against infection with Trypanosoma cruzi. Cross-immunization between five strains of the parasite using freeze-thawed vaccines containing epimastigotes of up to five strains.
    McHardy N; Elphick JP
    Int J Parasitol; 1978 Feb; 8(1):25-31. PubMed ID: 415993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.